evt 201
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT00380003)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- evt 201
- evt 201
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00401284 | Phase 2 | Nov 1, 2006 | Evotec, St Luke's Hospital, Chesterfield, MI |
| NCT00380003 | Phase 2 | Sep 1, 2006 | Evotec, St Luke's Hospital, Chesterfield, MI |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Evotec | For profit | 2 | 2 | 1 | 2006 |
| St Luke's Hospital, Chesterfield, MI | Academic/Hospital | 2 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1